If you made any changes in Pure these will be visible here soon.

Research Output 1993 2019

2019

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., Sep 1 2019, In : European Journal of Cancer. 118, p. 178-186 9 p.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival

Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer

Perrone, F., De Laurentiis, M., De Placido, S., Orditura, M., Cinieri, S., Riccardi, F., Ribecco, A. S., Putzu, C., Del Mastro, L., Rossi, E., Tinessa, V., Mosconi, A. M., Nuzzo, F., Di Rella, F., Gravina, A., Iodice, G., Landi, G., Pacilio, C., Forestieri, V., Lauria, R. & 12 others, Fabbri, A., Ibrahim, T., De Maio, E., Barni, S., Gori, S., Simeon, V., Arenare, L., Daniele, G., Piccirillo, M. C., Normanno, N., de Matteis, A. & Gallo, C., 2019, In : European Journal of Cancer.

Research output: Contribution to journalArticle

zoledronic acid
letrozole
Breast Neoplasms
Triptorelin Pamoate
Disease-Free Survival

Applicazioni cliniche del trastuzumab nel trattamento del carcinoma mammario HER2

Translated title of the contribution: Clinical applications of trastuzumab in the management of HER-2-positive breast cancerDel Mastro, L. & De Laurentiis, M., Dec 1 2019, In : Recenti Progressi in Medicina. 110, 12, p. 594-603 10 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Biosimilar Pharmaceuticals
Disease-Free Survival
Survival Rate
Trastuzumab

Cardiotoxicity and pro-inflammatory effects of the immune checkpoint inhibitor Pembrolizumab associated to Trastuzumab

Quagliariello, V., Passariello, M., Coppola, C., Rea, D., Barbieri, A., Scherillo, M., Monti, M. G., Iaffaioli, R. V., De Laurentiis, M., Ascierto, P. A., Botti, G., De Lorenzo, C. & Maurea, N., 2019, In : International Journal of Cardiology.

Research output: Contribution to journalArticle

NF-kappa B
Leukotriene B4
Cardiac Myocytes
Interleukins
Immunotherapy

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis

Giuliano, M., Schettini, F., Rognoni, C., Milani, M., Jerusalem, G., Bachelot, T., De Laurentiis, M., Thomas, G., De Placido, P., Arpino, G., De Placido, S., Cristofanilli, M., Giordano, A., Puglisi, F., Pistilli, B., Prat, A., Del Mastro, L., Venturini, S. & Generali, D., Oct 1 2019, In : The Lancet Oncology. 20, 10, p. 1360-1369 10 p.

Research output: Contribution to journalArticle

letrozole
Hormones
Breast Neoplasms
Drug Therapy
Therapeutics

Endocrine treatment versus chemotherapy in postmenopausal women with hormone receptor-positive, HER2-negative, metastatic breast cancer: a systematic review and network meta-analysis

Giuliano, M., Schettini, F., Rognoni, C., Milani, M., Jerusalem, G., Bachelot, T., De Laurentiis, M., Thomas, G., De Placido, P., Arpino, G., De Placido, S., Cristofanilli, M., Giordano, A., Puglisi, F., Pistilli, B., Prat, A., Del Mastro, L., Venturini, S. & Generali, D., Oct 2019, In : The Lancet. Oncology. 20, 10, p. 1360-1369 10 p.

Research output: Contribution to journalArticle

letrozole
Hormones
Breast Neoplasms
Drug Therapy
Therapeutics

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies

Cazzaniga, M. E., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Valerio, M. R., Airoldi, M., Moretti, G., Ficorella, C., Gianni, L., Michelotti, A., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 31 others, La Verde, N., Bianchi, G. V., Artale, S., Blasi, L., De Laurentiis, M., Atzori, F., Turletti, A., Porpiglia, M., Santini, D., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C., Clivio, L., Giordano, M., Donadio, M., Biganzoli, L., Del Mastro, L., Bisagni, G., Livi, L., Natoli, C., Montemurro, F., Riccardi, F., Romagnoli, E., Marchetti, P., Torri, V., Pronzato, P. & Mustacchi, G., Jan 1 2019, In : Breast Care.

Research output: Contribution to journalArticle

Extravehicular Activity
Breast Neoplasms
Therapeutics
Aromatase Inhibitors
Datasets

LncRNA HOTAIR up-regulation is strongly related with lymph nodes metastasis and LAR subtype of triple negative breast cancer

Collina, F., Aquino, G., Brogna, M., Cipolletta, S., Buonfanti, G., De Laurentiis, M., Bonito, M. D., Cantile, M. & Botti, G., Jan 1 2019, In : Journal of Cancer. 10, 9, p. 2018-2024 7 p.

Research output: Contribution to journalArticle

Open Access
Triple Negative Breast Neoplasms
Up-Regulation
Lymph Nodes
Neoplasm Metastasis
Androgen Receptors

Unexpected ovarian activity in premenopausal breast cancer survivors treated with exemestane and GnRH analogues

Conforti, A., Schettini, F., Vallone, R., Di Rella, F., De Rosa, P., De Santo, I., Giuliano, M., Arpino, G., Lauria, R., De Placido, S., Caputo, R., De Laurentiis, M., Nazzaro, G., De Placido, G., Locci, M. & Alviggi, C., Jan 1 2019, In : Breast Journal.

Research output: Contribution to journalComment/debate

2018
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms
exemestane
letrozole
Tamoxifen
Aromatase Inhibitors
Breast Neoplasms

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cogoni, A. A., Cognetti, F., Gori, S., Foglietta, J., Frassoldati, A., Amoroso, D., Laudadio, L., Moscetti, L., Montemurro, F., Verusio, C., Bernardo, A. & 209 others, Lorusso, V., Gravina, A., Moretti, G., Lauria, R., Lai, A., Mocerino, C., Rizzo, S., Nuzzo, F., Carlini, P., Perrone, F., Accurso, A., Agostara, B., Aieta, M., Alabiso, O., Alicicco, M. G., Amadori, D., Amaducci, L., Amiconi, G., Antuzzi, G., Ardine, M., Ardizzoia, A., Aversa, C., Badalamenti, G., Barni, S., Basurto, C., Berardi, R., Bergamasco, C., Bidoli, P., Bighin, C., Biondi, E., Bisagni, G., Boni, C., Borgonovo, K., Botta, M., Bravi, S., Bruzzi, P., Buono, G., Butera, A., Caldara, A., Candeloro, G., Cappelletti, C., Cardalesi, C., Carfora, E., Cariello, A., Carrozza, F., Cartenì, G., Caruso, M., Casadei, V., Casanova, C., Castori, L., Cavanna, L., Cavazzini, G., Cazzaniga, M., Chilelli, M., Chiodini, P., Chiorrini, S., Ciardiello, F., Ciccarese, M., Cinieri, S., Clerico, M., Coccaro, M., Comande, M., Corbo, C., Cortino, G., Cusenza, S., Daniele, G., D'arco, A. M., D'auria, G., Dazzi, C., De Angelis, C., de Braud, F., De Feo, G., De Matteis, A., De Tursi, M., Di Blasio, A., di Lucca, G., Di Lullo, L., Di Rella, F., Di Renzo, G., Di Stefano, P., Di Stefano, A., Diana, A., Donati, S., Fabbri, A., Fabi, A., Faedi, M., Farina, G., Farris, A., Febbraro, A., Fedele, P., Federico, P., Ferraù, F., Ferretti, G., Ferro, A., Floriani, I., Forcignanò, R., Forciniti, S., Forestieri, V., Fornari, G., Frisinghelli, M., Fusco, V., Gallizzi, G., Galvano, A., Gambardella, A., Gambi, A., Gebbia, V., Gervasi, E., Ghilardi, M., Giacobino, A., Giardina, G., Giotta, F., Giraudi, S., Giuliano, M., Grassadonia, A., Grasso, D., Grosso, F., Guizzaro, L., Incoronato, P., Incorvaia, L., Iodice, G., La Verde, N., Labonia, V., Landi, G., Latorre, A., Leonardi, V., Levaggi, A., Limite, G., Lina Bascialla, L., Livi, L., Maiello, E., Mandelli, D., Marcon, I., Menon, D., Montedoro, M., Moraca, L., Moretti, A., Morritti, M. G., Morselli, P., Mura, A., Mura, S., Musacchio, M., Muzio, A., Natale, D., Natoli, C., Nigro, C., Nisticò, C., Nuzzo, A., Orditura, M., Orlando, L., Pacilio, C., Palumbo, G., Palumbo, R., Pasini, F., Paterno, E., Pazzola, A., Pelliccioni, S., Pensabene, M., Perroni, D., Pesenti Gritti, A., Petrelli, F., Piccirillo, M. C., Pinotti, G., Pogliani, C., Poli, D., Prader, S., Recchia, F., Rizzi, D., Romano, C., Rossello, R., Rossini, C., Salvucci, G., Sanna, V., Santini, A., Saracchini, S., Savastano, C., Scambia, G., Schettini, F., Schiavone, P., Schirone, A., Seles, E., Signoriello, S., Signoriello, G., Silva, R. R., Silvestri, A., Simeon, V., Spagnoletti, I., Tamberi, S., Teragni, C., Thalmann, V., Thomas, R., Thomas, G., Tienghi, A., Tinari, N., Tinessa, V., Tomei, F., Tonini, G., Torri, V., Traficante, D., Tudini, M., Turazza, M., Vignoli, R., Vitale, M. G., Zacchia, A., Zagarese, P., Zanni, A., Zavallone, L., Zavettieri, M., Zoboli, A. & Investigators, GIM., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

De Placido, S., Gallo, C., De Laurentiis, M., Bisagni, G., Arpino, G., Sarobba, M. G., Riccardi, F., Russo, A., Del Mastro, L., Cognetti, F., Montemurro, F., Bernardo, A., Gravina, A., Nuzzo, F. & Perrone, F., 2018, In : The Lancet Oncology. 19, 4, p. 474-485 12 p.

Research output: Contribution to journalArticle

Adjuvant Subcutaneous Trastuzumab for HER2-Positive Early Breast Cancer: Subgroup Analyses of Safety and Active Medical Conditions by Body Weight in the SafeHer Phase III Study

Jung, K. H., Ataseven, B., Verrill, M., Pivot, X., De Laurentiis, M., Al-Sakaff, N., Lauer, S., Shing, M., Gligorov, J. & Azim, H. A., 2018, In : Oncologist.

Research output: Contribution to journalArticle

Body Weight
Breast Neoplasms
Safety
Population
Adjuvant Chemotherapy

Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

Gerratana, L., Basile, D., Buono, G., De Placido, S., Giuliano, M., Minichillo, S., Coinu, A., Martorana, F., De Santo, I., Del Mastro, L., De Laurentiis, M., Puglisi, F. & Arpino, G., Jul 2018, In : Cancer Treatment Reviews. 68, p. 102-110 9 p.

Research output: Contribution to journalReview article

Triple Negative Breast Neoplasms
Androgen Receptors
Neoadjuvant Therapy
Androgens
Breast Neoplasms

Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype

Gerratana, L., Basile, D., Buono, G., De Placido, S., Giuliano, M., Minichillo, S., Coinu, A., Martorana, F., De Santo, I., Del Mastro, L., De Laurentiis, M., Puglisi, F. & Arpino, G., Jul 1 2018, In : Cancer Treatment Reviews. 68, p. 102-110 9 p.

Research output: Contribution to journalReview article

Triple Negative Breast Neoplasms
Androgen Receptors
Neoadjuvant Therapy
Androgens
Breast Neoplasms

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

Pelizzari, G., Arpino, G., Biganzoli, L., Cinieri, S., De Laurentiis, M. & Di Leo, A., Sep 27 2018, In : BMC Cancer. 18, 1, 1 p.

Research output: Contribution to journalArticle

Delphi Technique
Breast Neoplasms
Therapeutics
Hormones
Guidelines

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

Pelizzari, G., Arpino, G., Biganzoli, L., Cinieri, S., De Laurentiis, M., Del Mastro, L., Di Leo, A., Gori, S., Guarneri, V., Marchetti, P. & Puglisi, F., 2018, In : BMC Cancer. 18, 1

Research output: Contribution to journalArticle

An Italian Delphi study to evaluate consensus on adjuvant endocrine therapy in premenopausal patients with breast cancer: the ERA project

Pelizzari, G., Arpino, G., Biganzoli, L., Cinieri, S., De Laurentiis, M., Di Leo, A., Guarneri, V., Marchetti, P. & Puglisi, F., Sep 27 2018, In : BMC Cancer. 18, 1, 932.

Research output: Contribution to journalArticle

Delphi Technique
Breast Neoplasms
Therapeutics
Hormones
Guidelines

Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2

Campone, M., Im, S. A., Iwata, H., Clemons, M., Ito, Y., Awada, A., Chia, S., Jagiełło-Gruszfeld, A., Pistilli, B., Tseng, L. M., Hurvitz, S., Masuda, N., Cortés, J., De Laurentiis, M., Arteaga, C. L., Jiang, Z., Jonat, W., Le Mouhaër, S., Sankaran, B., Bourdeau, L. & 3 others, El-Hashimy, M., Sellami, D. & Baselga, J., Nov 1 2018, In : European Journal of Cancer. 103, p. 147-154 8 p.

Research output: Contribution to journalArticle

Placebos
Phosphatidylinositol 3-Kinase
Hormones
Breast Neoplasms
Survival

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

Schettini, F., De Santo, I., Rea, C. G., De Placido, P., Formisano, L., Giuliano, M., Arpino, G., De Laurentiis, M., Puglisi, F., De Placido, S. & Del Mastro, L., 2018, In : Frontiers in Oncology. 8, p. 608

Research output: Contribution to journalReview article

Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
Breast Neoplasms
Neoplasms
Liposarcoma

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

Schettini, F., De Santo, I., Rea, C. G., De Placido, P., Formisano, L., Giuliano, M., Arpino, G., De Laurentiis, M., Puglisi, F., De Placido, S. & Del Mastro, L., 2018, In : Frontiers in Oncology. 8, 12 p., 608.

Research output: Contribution to journalReview article

Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
Breast Neoplasms
Neoplasms
Liposarcoma

CDK 4/6 Inhibitors as Single Agent in Advanced Solid Tumors

Schettini, F., De Santo, I., Rea, C. G., De Placido, P., Formisano, L., Giuliano, M., Arpino, G., De Laurentiis, M., Puglisi, F., De Placido, S. & Del Mastro, L., 2018, In : Frontiers in Oncology. 8, p. 608 1 p.

Research output: Contribution to journalArticle

Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
Breast Neoplasms
Neoplasms
Liposarcoma

Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey

Bonotto, M., Basile, D., Gerratana, L., Pelizzari, G., Bartoletti, M., Vitale, M. G., Fanotto, V., Lisanti, C., Mansutti, M., Minisini, A. M., Aprile, G., De Laurentiis, M., Montemurro, F., Del Mastro, L. & Puglisi, F., Aug 2018, In : Breast. 40, p. 45-52 8 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Therapeutics
Surveys and Questionnaires
Hospital Costs
Physiologic Monitoring

Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results

De Placido, S., Giuliano, M., Schettini, F., Von Arx, C., Buono, G., Riccardi, F., Cianniello, D., Caputo, R., Puglisi, F., Bonotto, M., Fabi, A., Bilancia, D., Ciccarese, M., Lorusso, V., Michelotti, A., Bruzzese, D., Veneziani, B. M., Locci, M., De Laurentiis, M. & Arpino, G., Apr 2018, In : Breast. 38, p. 86-91 6 p.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Population
docetaxel
Disease-Free Survival
Therapeutics

Human epidermal growth factor receptor 2 dual blockade with trastuzumab and pertuzumab in real life: Italian clinical practice versus the CLEOPATRA trial results

De Placido, S., Giuliano, M., Schettini, F., Von Arx, C., Buono, G., Riccardi, F., Cianniello, D., Caputo, R., Puglisi, F., Bonotto, M., Fabi, A., Bilancia, D., Ciccarese, M., Lorusso, V., Michelotti, A., Bruzzese, D., Veneziani, B. M., Locci, M., De Laurentiis, M. & Arpino, G., Apr 1 2018, In : Breast. 38, p. 86-91 6 p.

Research output: Contribution to journalArticle

Randomized Controlled Trials
Population
docetaxel
Disease-Free Survival
Therapeutics

Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational study

De Laurentiis, M., Bonfadini, C., Cilenti, G., Di Rella, F., Altavilla, G., Otero, M., Ardizzoia, A., Peverelli, G., Amoroso, D., Vecchio, S., Fiorio, E. & Orecchia, S., 2018, In : Supportive Care in Cancer.

Research output: Contribution to journalArticle

Anthracyclines
Cyclophosphamide
Nausea
Italy
Vomiting

Incidence of nausea and vomiting in breast cancer patients treated with anthracycline plus cyclophosphamide-based chemotherapy regimens in Italy: NAVY observational study

De Laurentiis, M., Bonfadini, C., Lorusso, V., Cilenti, G., Di Rella, F., Altavilla, G., Otero, M., Ardizzoia, A., Marchetti, P., Peverelli, G., Amoroso, D., Vecchio, S., Fiorio, E. & Orecchia, S., 2018, In : Supportive Care in Cancer. 26, 12, p. 4021-4029 9 p.

Research output: Contribution to journalArticle

Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3

Slamon, D. J., Neven, P., Chia, S., Fasching, P. A., De Laurentiis, M., Im, S-A., Petrakova, K., Bianchi, G. V., Esteva, F. J., Martín, M., Nusch, A., Sonke, G. S., De la Cruz-Merino, L., Beck, J. T., Pivot, X., Vidam, G., Wang, Y., Rodriguez Lorenc, K., Miller, M., Taran, T. & 1 others, Jerusalem, G., 2018, In : Journal of Clinical Oncology. p. JCO2018789909

Research output: Contribution to journalArticle

Hormones
Placebos
Neutropenia
Disease-Free Survival
human ERBB2 protein

Phase III randomized study of ribociclib and fulvestrant in hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: MONALEESA-3

Slamon, D. J., Neven, P., Chia, S., Fasching, P. A., De Laurentiis, M., Im, S-A., Petrakova, K., Bianchi, G. V., Esteva, F. J., Martín, M., Nusch, A., Sonke, G. S., De La Cruz-Merino, L., Beck, J. T., Pivot, X., Vidam, G., Wang, Y., Lorenc, K. R., Miller, M., Taran, T. & 1 others, Jerusalem, G., 2018, In : Journal of Clinical Oncology. 36, 24, p. 2465-2472 8 p.

Research output: Contribution to journalArticle

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

Tripathy, D., Im, S-A., Colleoni, M., Franke, F., Bardia, A., Harbeck, N., Hurvitz, S. A., Chow, L., Sohn, J., Lee, K. S., Campos-Gomez, S., Villanueva Vazquez, R., Jung, K. H., Babu, K. G., Wheatley-Price, P., De Laurentiis, M., Im, Y-H., Kuemmel, S., El-Saghir, N., Liu, M-C. & 6 others, Carlson, G., Hughes, G., Diaz-Padilla, I., Germa, C., Hirawat, S. & Lu, Y-S., Jul 2018, In : The Lancet. Oncology. 19, 7, p. 904-915 12 p.

Research output: Contribution to journalArticle

Hormones
Breast Neoplasms
letrozole
Placebos
Therapeutics

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

Tripathy, D., Im, S. A., Colleoni, M., Franke, F., Bardia, A., Harbeck, N., Hurvitz, S. A., Chow, L., Sohn, J., Lee, K. S., Campos-Gomez, S., Villanueva Vazquez, R., Jung, K. H., Babu, K. G., Wheatley-Price, P., De Laurentiis, M., Im, Y. H., Kuemmel, S., El-Saghir, N., Liu, M. C. & 6 others, Carlson, G., Hughes, G., Diaz-Padilla, I., Germa, C., Hirawat, S. & Lu, Y. S., 2018, In : The Lancet Oncology.

Research output: Contribution to journalArticle

Hormones
Breast Neoplasms
letrozole
Placebos
Therapeutics
2017

Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter?

Fabi, A., Giannarelli, D., Moscetti, L., Santini, D., Zambelli, A., Laurentiis, M. D., Caruso, M., Generali, D., Valle, E., Leonardi, V., Cannita, K., Arpino, G., Filippelli, G., Ferretti, G., Giampaglia, M., Montemurro, F., Nistico, C., Gasparro, S. & Cognetti, F., Dec 1 2017, In : Future Oncology. 13, p. 2791-2797 7 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Disease-Free Survival
Trastuzumab
ado-trastuzumab emtansine
pertuzumab

A meta-analytic review of the relationship of cancer coping selfefficacy with distress and quality of life

Chirico, A., Lucidi, F., Merluzzi, T. V., Alivernini, F., Laurentiis, M. D., Botti, G. & Giordano, A., Feb 27 2017, In : Oncotarget. 8, 22, p. 36800-36811 12 p.

Research output: Contribution to journalReview article

Quality of Life
Self Efficacy
Neoplasms
Social Adjustment
Equipment and Supplies

An interaction network approach to study the correlation between endocrine disrupting chemicals and breast cancer

Polo, A., Nittoli, C., Crispo, A., Langastro, T., Severino, L., Cocco, S., De Laurentiis, M., Ciliberto, G., Montella, M., Budillon, A. & Costantini, S., Jan 1 2017, In : Molecular BioSystems. 13, 12, p. 2687-2696 10 p.

Research output: Contribution to journalArticle

Endocrine Disruptors
Breast Neoplasms
Mycotoxins
Protein Interaction Maps
Proteins

Combined effect of obesity and diabetes on early breast cancer outcome: A prospective observational study

Buono, G., Crispo, A., Giuliano, M., de Angelis, C., Schettini, F., Forestieri, V., Lauria, R., Pensabene, M., de Laurentiis, M., Augustin, L. S. A., Amore, A., D'Aiuto, M., Tortoriello, R., Accurso, A., Cavalcanti, E., Botti, G., Montella, M., de Placido, S. & Arpino, G., Jan 1 2017, In : Oncotarget. 8, 70, p. 115709-115717 9 p.

Research output: Contribution to journalArticle

Observational Studies
Obesity
Prospective Studies
Breast Neoplasms
Survival

Dose-dense adjuvant chemotherapy in premenopausal breast cancer patients: A pooled analysis of the MIG1 and GIM2 phase III studies

Lambertini, M., Ceppi, M., Cognetti, F., Cavazzini, G., De Laurentiis, M., De Placido, S., Michelotti, A., Bisagni, G., Durando, A., Valle, E., Scotto, T., De Censi, A., Turletti, A., Benasso, M., Barni, S., Montemurro, F., Puglisi, F., Levaggi, A., Giraudi, S., Bighin, C. & 2 others, Bruzzi, P. & Del Mastro, L., 2017, In : European journal of cancer. 71, p. 227 1 p.

Research output: Contribution to journalArticle

Adjuvant Chemotherapy
Breast Neoplasms
Amenorrhea
Drug Therapy
Confidence Intervals

Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study

Cicchiello, F., Riva, F., Cazzaniga, M. E., Pedani, F., Nicolini, M., Butti, C., Liscia, N., Pogliani, C., Capri, G., Alù, M., Febbraro, A., Petrucelli, L., D'Onofrio, L., De Laurentiis, M., Pellegrini, D., Mentuccia, L., Cocciolone, V., Miraglio, E., Bajardi, E., Dester, M. & 49 others, Paternò, E., Guaitoli, G., Ferrarini, I., Gervasi, E., Licata, L., Benedetto, C., Andreis, D., Bordin, E., Ancona, C., Pizzuti, L., Fotia, V., Berardi, R., Airoldi, M., Arcangeli, V., Artale, S., Atzori, F., Ballerio, A., Bianchi, G. V., Blasi, L., Campidoglio, S., Ciccarese, M., Cursano, M. C., Piezzo, M., Fabi, A., Ferrari, L., Ferzi, A., Ficorella, C., Frassoldati, A., Fumagalli, A., Garrone, O., Gebbia, V., Generali, D., La Verde, N., Maur, M., Michelotti, A., Moretti, G., Musolino, A., Palumbo, R., Pistelli, M., Porpiglia, M., Sartori, D., Scavelli, C., Schirone, A., Turletti, A., Valerio, M. R., Vici, P., Zambelli, A., Clivio, L. & Torri, V., 2017, In : Breast. 35, p. 115-121 7 p.

Research output: Contribution to journalArticle

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: A multicenter study

Fabi, A., De Laurentiis, M., Caruso, M., Valle, E., Moscetti, L., Santini, D., Cannita, K., Carbognin, L., Ciccarese, M., Rossello, R., Arpino, G., Leonardi, V., Montemurro, F., La Verde, N., Generali, D., Zambelli, A., Scandurra, G., Russillo, M., Paris, I., D'Ottavio, A. M. & 8 others, Filippelli, G., Giampaglia, M., Stani, S., Fabbri, A., Alesini, D., Cianniello, D., Giannarelli, D. & Cognetti, F., 2017, In : Oncotarget. 8, 38, p. 64481-64489 9 p.

Research output: Contribution to journalArticle

Multicenter Studies
Breast Neoplasms
Safety
Therapeutics
Neoplasm Metastasis

Efficacy and safety of T-DM1 in the 'common-practice' of HER2+ advanced breast cancer setting: a multicenter study.

Fabi, A., De Laurentiis, M., Caruso, M., Valle, E., Moscetti, L., Santini, D., Cannita, K., Carbognin, L., Ciccarese, M., Rossello, R., Arpino, G., Leonardi, V., Montemurro, F., La Verde, N., Generali, D., Zambelli, A., Scandurra, G., Russillo, M., Paris, I., D'Ottavio, A. M. & 8 others, Filippelli, G., Giampaglia, M., Stani, S., Fabbri, A., Alesini, D., Cianniello, D., Giannarelli, D. & Cognetti, F., Sep 1 2017, In : Oncotarget. 8, p. 64481-64489 9 p.

Research output: Contribution to journalArticle

Multicenter Studies
Breast Neoplasms
Safety
Therapeutics
Neoplasm Metastasis

Eribulin as an effective monotherapy in a chemo-pretreated woman with metastatic breast cancer: A case report

Caputo, R., Cianniello, D. & De Laurentiis, M., May 1 2017, In : Future Oncology. 13, 11s, p. 45-50 6 p.

Research output: Contribution to journalArticle

eribulin
Anthracyclines
Breast Neoplasms
Taxoids
Cytotoxins

Glucose impairs tamoxifen responsiveness modulating connective tissue growth factor in breast cancer cells

Ambrosio, M. R., D'Esposito, V., Costa, V., Liguoro, D., Collina, F., Cantile, M., Prevete, N., Passaro, C., Mosca, G., De Laurentiis, M., Di Bonito, M., Botti, G., Franco, R., Beguinot, F., Ciccodicola, A. & Formisano, P., Jan 1 2017, In : Oncotarget. 8, 65, p. 109000-109017 18 p.

Research output: Contribution to journalArticle

Connective Tissue Growth Factor
Tamoxifen
Breast Neoplasms
Glucose
MCF-7 Cells

High progesterone levels during the luteal phase related to the use of an aromatase inhibitor in breast cancer patients

Alviggi, C., Marci, R., Vallone, R., Conforti, A., Di Rella, F., Strina, I., Picarelli, S., De Rosa, P., De Laurentiis, M., Yding Andersen, C. & De Placido, G., 2017, In : European Review for Medical and Pharmacological Sciences. 21, 13, p. 3134-3138 5 p.

Research output: Contribution to journalArticle

letrozole
Aromatase Inhibitors
Luteal Phase
Progesterone
Breast Neoplasms

Imaging tests in staging and surveillance of non-metastatic breast cancer: Changes in routine clinical practice and cost implications

De Placido, S., De Angelis, C., Giuliano, M., Pizzi, C., Ruocco, R., Perrone, V., Bruzzese, D., Tommasielli, G., De Laurentiis, M., Cammarota, S. & Arpino, G., Mar 14 2017, In : British Journal of Cancer. 116, 6, p. 821-827 7 p.

Research output: Contribution to journalArticle

Breast Neoplasms
Costs and Cost Analysis
Positron-Emission Tomography
Prescriptions
Tomography

Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

Kim, S-B., Maslyar, D. J., Dent, R., Im, S-A., Espié, M., Blau, S., Tan, A. R., Isakoff, S., Oliveira, M., Saura, C., Wongchenko, M. J., Kapp, A. V., Chan, W. Y., Singel, S. M., Baselga, J., Kim, S-B., Lee, K. S., Im, S-A., Espié, M., Wang, H-C. & 39 others, Blau, S., Dent, R., Tan, A., Sohn, J. H., De Laurentiis, M., Estevez, L. G., Huang, C-S., Romieu, G., Velez, M., Villanueva, R., Conte, P. F., Dakhil, S., Debled, M., Martin, A. G., Hurvitz, S., Kim, J. H., Levy, C., Oliveira, M., Rovira, P. S., Seo, J. H., Valero, V., Vidal, G., Wong, A., Allison, M. A. K., Figlin, R., Chan, D., Chen, S-C., Chen, Y-H., Cobleigh, M., De Braud, F., Dirix, L., Hansen, V., Bessard, A. H., Iannotti, N., Isakoff, S., Lawler, W., Montaño, A., Salkini, M. & Seigel, L., 2017, In : The Lancet Oncology. 18, 10, p. 1360-1372 13 p.

Research output: Contribution to journalArticle

Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DediCa): Design of a clinical trial

Augustin, L. S. A., Libra, M., Crispo, A., Grimaldi, M., De Laurentiis, M., Rinaldo, M., D'Aiuto, M., Catalano, F., Banna, G. L., Ferrau', F., Rossello, R., Serraino, D., Bidoli, E., Massarut, S., Thomas, G., Gatti, D., Cavalcanti, E., Pinto, M., Riccardi, G., Vidgen, E. & 4 others, Kendall, C. W. C., Jenkins, D. J. A., Ciliberto, G. & Montella, M., Jan 23 2017, In : BMC Cancer. 17, 1, 69.

Research output: Contribution to journalArticle

Glycemic Index
Vitamin D
Clinical Trials
Exercise
Breast Neoplasms

Low glycemic index diet, exercise and vitamin D to reduce breast cancer recurrence (DediCa): Design of a clinical trial

Augustin, L. S. A., Libra, M., Crispo, A., Grimaldi, M., De Laurentiis, M., Rinaldo, M., D'Aiuto, M., Catalano, F., Banna, G., Ferrau', F., Rossello, R., Serraino, D., Bidoli, E., Massarut, S., Thomas, G., Gatti, D., Cavalcanti, E., Pinto, M., Riccardi, G., Vidgen, E. & 4 others, Kendall, C. W. C., Jenkins, D. J. A., Ciliberto, G. & Montella, M., 2017, In : BMC Cancer. 17, 1

Research output: Contribution to journalArticle

Glycemic Index
Vitamin D
Clinical Trials
Exercise
Breast Neoplasms

Luminal-like HER2-negative stage IA breast cancer: A multicenter retrospective study on long-term outcome with propensity score analysis

De Angelis, C. D., Di Maio, M. D., Crispo, A., Giuliano, M., Schettini, F., Bonotto, M., Gerratana, L., Iacono, D., Cinausero, M., Riccardi, F., Ciancia, G., Laurentiis, M. D., Puglisi, F., De Placido, S. D. & Arpino, G., Jan 1 2017, In : Oncotarget. 8, 68, p. 112816-112824 9 p.

Research output: Contribution to journalArticle

Propensity Score
Phenobarbital
Multicenter Studies
Retrospective Studies
Breast Neoplasms

Programmed death ligand 1 (PD-L1) tumor expression is associated with a better prognosis and diabetic disease in triple negative breast cancer patients

Botti, G., Collina, F., Scognamiglio, G., Rao, F., Peluso, V., De Cecio, R., Piezzo, M., Landi, G., De Laurentiis, M., Cantile, M. & Di Bonito, M., Feb 21 2017, In : International Journal of Molecular Sciences. 18, 2, 459.

Research output: Contribution to journalArticle

Triple Negative Breast Neoplasms
prognosis
death
breast
Tumors